Identification of targetable FGFR gene fusions in diverse cancers. Read more about Identification of targetable FGFR gene fusions in diverse cancers.
Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Read more about Targeting MYCN in neuroblastoma by BET bromodomain inhibition.
MicroRNAs play a big role in regulating ovarian cancer-associated fibroblasts and the tumor microenvironment. Read more about MicroRNAs play a big role in regulating ovarian cancer-associated fibroblasts and the tumor microenvironment.
The promise of combining inhibition of PI3K and PARP as cancer therapy. Read more about The promise of combining inhibition of PI3K and PARP as cancer therapy.
Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia. Read more about Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia.
Oncogenic and wild-type Ras play divergent roles in the regulation of mitogen-activated protein kinase signaling. Read more about Oncogenic and wild-type Ras play divergent roles in the regulation of mitogen-activated protein kinase signaling.
Measuring oncogenic signaling pathways in cancer with PET: an emerging paradigm from studies in castration-resistant prostate cancer. Read more about Measuring oncogenic signaling pathways in cancer with PET: an emerging paradigm from studies in castration-resistant prostate cancer.
Histology, anatomy, or geography? Exome sequencing begins to delineate somatic mutational differences in esophageal cancer. Read more about Histology, anatomy, or geography? Exome sequencing begins to delineate somatic mutational differences in esophageal cancer.
Resiliency of lung cancers to EGFR inhibitor treatment unveiled, offering opportunities to divide and conquer EGFR inhibitor resistance. Read more about Resiliency of lung cancers to EGFR inhibitor treatment unveiled, offering opportunities to divide and conquer EGFR inhibitor resistance.
